Yahoo Web Search

Search results

1. • 

     Best Medicare Supplement Plan G Companies in 2024 - NerdWallet

     Nerdwallet· 8 hours ago

     Check out the best options for Medicare Supplement Plan G based on pricing, customer satisfaction...

2. • 

     AARP Medicare Advantage 2024 Review - NerdWallet

     Nerdwallet· 4 days ago

     Backed by big hitter UnitedHealthcare, AARP Medicare Advantage plans have low-cost options and just-above-average star ratings.

3. • Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcrip

     Guru Focus· 1 day ago

     For the complete transcript of the earnings call, please refer to the full earnings call transcript. Senseonics Holdings Inc (SENS, Financial) reported a 22% growth in total revenue, reaching ...

4. • 

     MultiCare and Premera Blue Shield negotiating new contract with June 1 deadline

     Yakima Herald-Republic· 5 days ago

     The Tacoma-based MultiCare Health System has notified thousands of clients across Washington their...

5. • 

     Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 day ago

     Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript May 11, 2024 Embecta Corp. isn’t one of...

6. • 

     Americans prepare to keep working through retirement

     Newsweek· 6 days ago

     In an Allianz Life study, 63 percent of respondents said they would likely continue working at least part-time during their retirement to supplement...

7. • CNO Financial Group (NYSE:CNO) Hits New 12-Month High at $28.44

     ETF DAILY NEWS· 3 days ago

     CNO Financial Group, Inc. (NYSE:CNO – Get Free Report) shares reached a new 52-week high on Friday . Piper Sandler upgraded shares of CNO Financial Group from a “neutral” rating to an “overweight ...

8. • Jaguar Health Reports First Quarter 2024 Financial Results

     The Joplin Globe· 5 hours ago

     The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net Q1 2023 revenue of $2.0 million and increased approximately 4%

9. • Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

     WPRI Providence· 1 day ago

     Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM ...